HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft.

Abstract
Severe thrombocytopenia developed after an allogeneic bone-marrow graft in a 40-year-old woman in first remission from acute myeloblastic leukaemia. The thrombocytopenia had an autoimmune basis and was acquired from the bone-marrow donor who had an identical platelet autoantibody. The patient responded to high-dose intravenous IgG, and she has a normal platelet count 10 months after the graft. This study suggests that the immune defect in autoimmune thrombocytopenia can be transferred in cells capable of proliferating in a bone-marrow graft.
AuthorsR M Minchinton, A H Waters, J Kendra, A J Barrett
JournalLancet (London, England) (Lancet) Vol. 2 Issue 8299 Pg. 627-9 (Sep 18 1982) ISSN: 0140-6736 [Print] England
PMID6125775 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Immunoglobulin G
  • Immunoglobulin M
Topics
  • Adult
  • Autoantibodies (analysis)
  • Blood Platelets (immunology)
  • Bone Marrow Transplantation
  • Female
  • Humans
  • Immunoglobulin G (administration & dosage)
  • Immunoglobulin M (analysis, immunology)
  • Leukemia, Myeloid, Acute (therapy)
  • Postoperative Complications (blood)
  • Thrombocytopenia (etiology, immunology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: